Blueberries Medical Corp.
Blueberries Medical Corp. (CSE: BBM | OTCQB: BBRRF) operates as a premier Latin American licensed producer focused on the cultivation, processing, and distribution of naturally grown, premium quality cannabis. Guided by a multidisciplinary leadership team with deep background in industrial agriculture, plant genetics, specialized extraction, medicine, and international pharmacology, the enterprise is fully authorized to navigate the global medical marketplace. The company holds comprehensive regulatory permits required for the commercial cultivation, domestic distribution, and international export of both CBD and THC-based medical cannabis solutions.
Agricultural and manufacturing operations are ideally situated within the fertile Bogotá Savanna of central Colombia, while simultaneously establishing a strategic operational presence in Argentina. By combining the unique geographic and cost advantages of these regions with advanced scientific testing and standardized extraction protocols, Blueberries is uniquely positioned to become a leading international supplier of medicinal-grade cannabis oil extracts. This balanced commercial model allows the business to deliver reliable, highly consistent therapeutic raw materials to pharmaceutical networks and healthcare partners across multiple global markets.
Transactions
This announcement as a matter of record only
PowerOne acted as Finder in connection with this financing
About
PowerOne provides early stage capital and advisory services to emerging growth companies. Since inception in 2003, PowerOne has assisted private and public companies across an array of sectors globally.
PowerOne is an Exempt Market Dealer and is registered in Ontario, British Columbia, Alberta, Saskatchewan, Manitoba, Nova Scotia and Quebec.
